Literature DB >> 9231688

Hyperbaric oxygen treatment for radiation proctitis.

T C Woo1, D Joseph, H Oxer.   

Abstract

PURPOSE: Our objective was to assess, retrospectively, the efficacy of hyperbaric oxygen treatment in radiation proctitis in all patients who have completed treatment for this disease at the Fremantle Hyperbaric Oxygen Unit. This unit is the only one of its kind in Western Australia. METHODS AND MATERIALS: Patients were assessed by a review of hospital records, blood bank records, and clinic review (if this was convenient), and all patients responded to a telephone survey. Patients were questioned regarding radiation proctitis symptoms and the degree to which each had improved.
RESULTS: Most patients had previously been treated with radiotherapy for prostate carcinoma. Patients with proctitis mainly suffered from bleeding, diarrhoea, incontinence, and pain. In more than half of these patients, symptoms partially or completely resolved after hyperbaric oxygen treatment.
CONCLUSION: Radiation-induced proctitis is a difficult clinical problem to treat and will probably become more significant with the rising incidence of diagnosis of prostate cancer. Hyperbaric Oxygen should be considered in the treatment of radiation-induced proctitis. Further prospective trials with strict protocol guidelines are warranted.

Entities:  

Mesh:

Year:  1997        PMID: 9231688     DOI: 10.1016/s0360-3016(97)00017-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Radiation-induced Proctitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

Review 2.  Hyperbaric oxygen for the treatment of radiation cystitis and proctitis.

Authors:  Ronald D Ennis
Journal:  Curr Urol Rep       Date:  2002-06       Impact factor: 3.092

3.  [Comment. Hyperbaric oxygenation (HBO) in the treatment of radiogenic side effects. Clinical experiences are decisive!].

Authors:  K A Hartmann; M Almeling; U M Carl; G Schmitt
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

4.  Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy.

Authors:  Roberto Zinicola; Matthew D Rutter; Giuliano Falasco; Jim C Brooker; Vincenzo Cennamo; Sandro Contini; Brian P Saunders
Journal:  Int J Colorectal Dis       Date:  2003-04-04       Impact factor: 2.571

Review 5.  A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.

Authors:  M E Schutzer; P F Orio; M C Biagioli; D A Asher; H Lomas; D Moghanaki
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-02-17       Impact factor: 5.554

Review 6.  Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.

Authors:  Rachel J Gibson; Dorothy M K Keefe; Rajesh V Lalla; Emma Bateman; Nicole Blijlevens; Margot Fijlstra; Emily E King; Andrea M Stringer; Walter J F M van der Velden; Roger Yazbeck; Sharon Elad; Joanne M Bowen
Journal:  Support Care Cancer       Date:  2012-11-10       Impact factor: 3.603

7.  The utility of hyperbaric oxygen therapy to treat recurrent acute bowel obstruction after previous pelvic radiotherapy: a case series.

Authors:  M J Abu-Asi; H J N Andreyev
Journal:  Support Care Cancer       Date:  2013-04-27       Impact factor: 3.603

Review 8.  Systematic review of hyperbaric oxygen therapy for the treatment of non-neurological soft tissue radiation-related injuries.

Authors:  Benjamin L Hoggan; Alun L Cameron
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

9.  Radiation colitis and proctitis.

Authors:  Gregory D Kennedy; Charles P Heise
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 10.  Treatment of radiation proctitis with hyperbaric oxygen: what is the optimal number of HBO treatments?

Authors:  U M Carl; D Peusch-Dreyer; T Frieling; G Schmitt; K A Hartmann
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.